236 related articles for article (PubMed ID: 9824624)
1. Comparative analysis of matrix metalloproteinases by immunocytochemistry, immunohistochemistry and zymography in human primary brain tumours.
Rooprai HK; Van Meter T; Rucklidge GJ; Hudson L; Everall IP; Pilkington GJ
Int J Oncol; 1998 Dec; 13(6):1153-7. PubMed ID: 9824624
[TBL] [Abstract][Full Text] [Related]
2. Spatiotemporal expression patterns of metalloproteinases and their inhibitors in the postnatal developing rat cerebellum.
Vaillant C; Didier-Bazès M; Hutter A; Belin MF; Thomasset N
J Neurosci; 1999 Jun; 19(12):4994-5004. PubMed ID: 10366632
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size.
Romanic AM; White RF; Arleth AJ; Ohlstein EH; Barone FC
Stroke; 1998 May; 29(5):1020-30. PubMed ID: 9596253
[TBL] [Abstract][Full Text] [Related]
4. An inverse correlation between expression of NCAM-A and the matrix-metalloproteinases gelatinase-A and gelatinase-B in human glioma cells in vitro.
Maidment SL; Rucklidge GJ; Rooprai HK; Pilkington GJ
Cancer Lett; 1997 Jun; 116(1):71-7. PubMed ID: 9177460
[TBL] [Abstract][Full Text] [Related]
5. Regulatory role of extracellular matrix components in expression of matrix metalloproteinases in cultured hepatic stellate cells.
Li YL; Sato M; Kojima N; Miura M; Senoo H
Cell Struct Funct; 1999 Oct; 24(5):255-61. PubMed ID: 15216880
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of fluorometric and zymographic methods as activity assays for stromelysins and gelatinases.
Quesada AR; Barbacid MM; Mira E; Fernández-Resa P; Márquez G; Aracil M
Clin Exp Metastasis; 1997 Jan; 15(1):26-32. PubMed ID: 9009103
[TBL] [Abstract][Full Text] [Related]
7. Localization of matrix metalloproteinases and tissue inhibitor of metalloproteinases-2 in normal human and rabbit stomachs.
Tatsuguchi A; Fukuda Y; Ishizaki M; Yamanaka N
Digestion; 1999; 60(3):246-54. PubMed ID: 10343138
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas.
Nakano A; Tani E; Miyazaki K; Yamamoto Y; Furuyama J
J Neurosurg; 1995 Aug; 83(2):298-307. PubMed ID: 7616276
[TBL] [Abstract][Full Text] [Related]
9. Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are related to the overall survival of patients with gastric carcinoma.
Sier CF; Kubben FJ; Ganesh S; Heerding MM; Griffioen G; Hanemaaijer R; van Krieken JH; Lamers CB; Verspaget HW
Br J Cancer; 1996 Aug; 74(3):413-7. PubMed ID: 8695357
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro.
Yamamoto M; Mohanam S; Sawaya R; Fuller GN; Seiki M; Sato H; Gokaslan ZL; Liotta LA; Nicolson GL; Rao JS
Cancer Res; 1996 Jan; 56(2):384-92. PubMed ID: 8542596
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinases MMP-2 and MMP-9 in denervated muscle and injured nerve.
Kherif S; Dehaupas M; Lafuma C; Fardeau M; Alameddine HS
Neuropathol Appl Neurobiol; 1998 Aug; 24(4):309-19. PubMed ID: 9775397
[TBL] [Abstract][Full Text] [Related]
12. Assay of matrix metalloproteinases types 1, 2, 3 and 9 in breast cancer.
Remacle AG; Noël A; Duggan C; McDermott E; O'Higgins N; Foidart JM; Duffy MJ
Br J Cancer; 1998 Mar; 77(6):926-31. PubMed ID: 9528836
[TBL] [Abstract][Full Text] [Related]
13. Roles of membrane type 1 matrix metalloproteinase and tissue inhibitor of metalloproteinases 2 in invasion and dissemination of human malignant glioma.
Nakada M; Kita D; Futami K; Yamashita J; Fujimoto N; Sato H; Okada Y
J Neurosurg; 2001 Mar; 94(3):464-73. PubMed ID: 11235952
[TBL] [Abstract][Full Text] [Related]
14. Vascular extracellular matrix remodeling in cerebral aneurysms.
Bruno G; Todor R; Lewis I; Chyatte D
J Neurosurg; 1998 Sep; 89(3):431-40. PubMed ID: 9724118
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinases 2 and 9 in equine synovial fluids.
Clegg PD; Coughlan AR; Riggs CM; Carter SD
Equine Vet J; 1997 Sep; 29(5):343-8. PubMed ID: 9306059
[TBL] [Abstract][Full Text] [Related]
16. Expression of 72 kDa and 92 kDa type IV collagenases from human giant-cell tumor of bone.
Rao VH; Bridge JA; Neff JR; Schaefer GB; Buehler BA; Vishwanatha JK; Pollock RE; Nicolson GL; Yamamoto M; Gokaslam ZL
Clin Exp Metastasis; 1995 Nov; 13(6):420-6. PubMed ID: 7586800
[TBL] [Abstract][Full Text] [Related]
17. Characterization of matrix metalloproteinases in human urine: alterations during adolescence.
Thrailkill KM; Kumar S; Rosenberg CK; Auten KJ; Fowlkes JL
Pediatr Nephrol; 1999 Apr; 13(3):223-9. PubMed ID: 10353410
[TBL] [Abstract][Full Text] [Related]
18. 92K-GL (MMP-9) and 72K-GL (MMP-2) are produced in vivo by human oral squamous cell carcinomas and can enhance FIB-CL (MMP-1) activity in vitro.
Pickett KL; Harber GJ; DeCarlo AA; Louis P; Shaneyfelt S; Windsor LJ; Bodden MK
J Dent Res; 1999 Jul; 78(7):1354-61. PubMed ID: 10403463
[TBL] [Abstract][Full Text] [Related]
19. The effect of exogenous gangliosides on matrix metalloproteinase secretion by human glioma cells in vitro.
Maidment SL; Merzak A; Koochekpour S; Rooprai HK; Rucklidge GJ; Pilkington GJ
Eur J Cancer; 1996 May; 32A(5):868-71. PubMed ID: 9081368
[TBL] [Abstract][Full Text] [Related]
20. Comparison of techniques for measurement of gelatinases/type IV collagenases: enzyme-linked immunoassays versus substrate degradation assays.
Zucker S; Mancuso P; DiMassimo B; Lysik RM; Conner C; Wu CL
Clin Exp Metastasis; 1994 Jan; 12(1):13-23. PubMed ID: 8287615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
